SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-011931
Filing Date
2022-05-03
Accepted
2022-05-03 16:20:44
Documents
42
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 521317
2 ex31-1.htm EX-31.1 36953
3 ex32-1.htm EX-32.1 8832
  Complete submission text file 0001493152-22-011931.txt   2928946

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imun-20220331.xsd EX-101.SCH 33861
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imun-20220331_cal.xml EX-101.CAL 28412
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imun-20220331_def.xml EX-101.DEF 68962
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imun-20220331_lab.xml EX-101.LAB 218811
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imun-20220331_pre.xml EX-101.PRE 146425
36 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 414066
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 22887231
SIC: 2834 Pharmaceutical Preparations